In addition, Juglone (Kim et al., 2009) and ATRA (Wei et al., 2015) have been shown to potently reduce PIN1’s oncogenic activity in breast cancer models; however, the efficacy of these drugs on reducing MYC’s oncogenic activity remains to be studied. The gene discussed is MYC; the disease is breast carcinoma.